A Gene Chip Based Predictive Biomarker for Oral Cancer Metastasis

Oral cancer is the most common cancer typa in Inda.Age adjusted rates of oral cancer in India is 20 per 100,000 population and acounts for over 30% of all cancers in the country.

A gene expression chip comprised of 34 genes that predicts nodal metastatic subset of early stage oral cancer with high specificity.

A gene expression chip comprised of 34 genes that predict nodal metastatic subset of early stage oral cancer with high specificity. Will allow to detect whether or not an early stage oral tumor has nodal metastasis, help Onco Surgeon to decide whether not to do aggressive surgery.

1. Will allow to detect whether or not an early stage oral tumor has nodal metastasis.

2. This will help onco-surgeon to decide whether not to de aggresive surgery.

3. Approxomate number of early stage oral cancer pateint would be 75,000/year

4. projeted market value would be 150cr/year(assuming an asay cost of Rs. 20,000/-)